Merck Settles Keytruda Patent Suit For $19.5M
Merck Sharp & Dohme Corp. and PDL BioPharma Inc. have called a truce in a patent infringement dispute over Merck's cancer drug Keytruda, as the companies announced Monday that Merck will...To view the full article, register now.
Already a subscriber? Click here to view full article